Massachusetts General Hospital: Depressive Disorder trials

The registry lists 110 Depressive Disorder studies with Massachusetts General Hospital as lead sponsor. 3 are open to participants now and 58 have results posted.

Phase 1 1Phase 2 15Phase 3 7Phase 4 22No phase 66(a study in two phases counts in both)

Studies

Page 2 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Therapy Targeting Depression and HIV Treatment Adherence (The TRIAD Study)CompletedNCT00951028Not applicable
• Neuroimaging for DepressionTerminatedNCT00864630Not applicable
• Cognitive Deficits in Major Depressive Disorder and Bipolar Disorder, Depressed Type: Prevalence and Improvement With Treatment of Depressive SymptomsCompletedNCT00844974Not applicable
• Neural Correlates of Psychodynamic Psychotherapy for DepressionCompletedNCT00812227Not applicable
• Effectiveness of Cognitive Behavioral Therapy for Treating Depression in People With Bipolar I DisorderCompletedNCT00595387Not applicable
• Biochemical Brain Changes Correlated With The Antidepressant Effect Of Thyroid HormonesCompletedNCT00562367Not applicable
• A Study of 6(S)-5-MTHF Among Serotonin Reuptake Inhibitor(SSRI)-Resistant Outpatients With Major Depressive Disorder (MDD)CompletedNCT00321152Phase 4
• Effectiveness of Pramipexole for Treatment-Resistant DepressionCompletedNCT00231959Phase 4
• Bupropion SR for Major Depression and Depression NOS in Children and Adolescents With Bipolar DisorderTerminatedNCT00181896Phase 4
• Quantitative EEG (QEEG) as a Predictor of Treatment Outcome in DepressionCompletedNCT00157547Phase 4